Insider Transactions in Q3 2024 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 04
2024
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
518
-0.39%
|
$1,554
$3.42 P/Share
|
|
Sep 04
2024
|
Gilmore Neil O'Neill CEO |
SELL
Open market or private sale
|
Direct |
1,555
-0.49%
|
$4,665
$3.42 P/Share
|
|
Jul 25
2024
|
Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
11,886
-13.98%
|
$59,430
$5.42 P/Share
|
|
Jul 19
2024
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,619
-4.69%
|
$33,095
$5.21 P/Share
|